Chalcogenopyrylium Dyes as Differential Modulators of Organic Anion Transport by Multidrug Resistance Protein 1 (MRP1), MRP2, and MRP4

被引:15
|
作者
Myette, Robert L. [1 ]
Conseil, Gwenaelle [2 ]
Ebert, Sean P. [3 ]
Wetzel, Bryan [3 ]
Detty, Michael R. [3 ]
Cole, Susan P. C. [1 ,2 ]
机构
[1] Queens Univ, Canc Res Inst, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada
[3] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
BINDING CASSETTE TRANSPORTERS; P-GLYCOPROTEIN; DRUG-RESISTANCE; CHALCOGENAPYRYLIUM DYES; METHOTREXATE TRANSPORT; SELECTIVE MODULATORS; CELLS; INHIBITION; PACLITAXEL; AGENTS;
D O I
10.1124/dmd.112.050831
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multidrug resistance proteins (MRPs) mediate the ATP-dependent efflux of structurally diverse compounds, including anticancer drugs and physiologic organic anions. Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of [H-3]estradiol glucuronide (E(2)17 beta G; a prototypical MRP substrate) into MRP-enriched inside-out membrane vesicles. Additionally, some CGPs were tested in intact transfected cells using a calcein efflux assay. Sixteen of 34 CGPs inhibited MRP1-mediated E(2)17 beta G uptake by >50% (IC50 values: 0.7-7.6 mu M). Of 9 CGPs with IC50 values <= 2 mu M, two belonged to class I, two to class III, and five to class V. When tested in the intact cells, only 4 of 16 CGPs (at 10 mu M) inhibited MRP1-mediated calcein efflux by >50% (III-1, V-3, V-4, V-6), whereas a fifth (I-5) inhibited efflux by just 23%. These five CGPs also inhibited [H-3]E(2)17 beta G uptake by MRP4. In contrast, their effects on MRP2 varied, with two (V-4, V-6) inhibiting E(2)17 beta G transport (IC50 values: 2.0 and 9.2 mu M) and two (V-3, III-1) stimulating transport (>2-fold), whereas CGP I-5 had no effect. Strikingly, although V-3 and V-4 had opposite effects on MRP2 activity, they are structurally identical except for their chalcogen atom (Se versus Te). This study is the first to identify class V CGPs, with their distinctive methine or trimethine linkage between two disubstituted pyrylium moieties, as a particularly potent class of MRP modulators, and to show that, within this core structure, differences in the electronegativity associated with a chalcogen atom can be the sole determinant of whether a compound will stimulate or inhibit MRP2.
引用
收藏
页码:1231 / 1239
页数:9
相关论文
共 50 条
  • [1] Cannabinoid Type 1 Receptor Antagonists Modulate Transport Activity of Multidrug Resistance-Associated Proteins MRP1, MRP2, MRP3, and MRP4
    Wittgen, Hanneke G. M.
    van den Heuvel, Jeroen J. M. W.
    van den Broek, Petra H. H.
    Dinter-Heidorn, Heike
    Koenderink, Jan B.
    Russel, Frans G. M.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (07) : 1294 - 1302
  • [2] Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions
    Bakos, É
    Evers, R
    Sinkó, E
    Váradi, A
    Borst, P
    Sarkadi, B
    MOLECULAR PHARMACOLOGY, 2000, 57 (04) : 760 - 768
  • [3] Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
    Keppler, D
    Leier, I
    Jedlitschky, G
    BIOLOGICAL CHEMISTRY, 1997, 378 (08) : 787 - 791
  • [4] Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2
    Hooijberg, JH
    Broxterman, HJ
    Kool, M
    Assaraf, YG
    Peters, GJ
    Noordhuis, P
    Scheper, RJ
    Borst, P
    Pinedo, MM
    Jansen, G
    CANCER RESEARCH, 1999, 59 (11) : 2532 - 2535
  • [5] Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3
    Chu, XY
    Huskey, SEW
    Braun, MP
    Sarkadi, B
    Evans, DC
    Evers, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01): : 156 - 164
  • [6] Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
    Kool, M
    deHaas, M
    Scheffer, GL
    Scheper, RJ
    vanEijk, MJT
    Juijn, JA
    Baas, F
    Borst, P
    CANCER RESEARCH, 1997, 57 (16) : 3537 - 3547
  • [7] Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport
    Zhao, Xiaofen
    Li, Yangfang
    Du, Kun
    Wu, Yuqin
    Liu, Ling
    Cui, Shan
    Zhang, Yan
    Gao, Jin
    Keep, Richard F.
    Xiang, Jianming
    PLOS ONE, 2019, 14 (11):
  • [8] The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis
    Hooijberg, JH
    Peters, GJ
    Assaraf, YG
    Kathmann, I
    Priest, DG
    Bunni, MA
    Veerman, AJP
    Scheffer, GL
    Kaspers, GJL
    Jansen, G
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (05) : 765 - 771
  • [9] Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2)
    Williams, GC
    Liu, A
    Knipp, G
    Sinko, PJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3456 - 3462
  • [10] Peptide transport by the multidrug resistance protein MRP1
    de Jong, MC
    Slootstra, JW
    Scheffer, GL
    Schroeijers, AB
    Puijk, WC
    Dinkelberg, R
    Kool, M
    Broxterman, HJ
    Meloen, RH
    Scheper, RJ
    CANCER RESEARCH, 2001, 61 (06) : 2552 - 2557